Asia Pacific Cold And Flu Supplements Market Size & Outlook
Asia Pacific cold and flu supplements market, 2017-2030 (US$M)
Related Markets
Asia Pacific cold and flu supplements market highlights
- The Asia Pacific cold and flu supplements market generated a revenue of USD 4,611.6 million in 2022.
- The market is expected to grow at a CAGR of 12.2% from 2023 to 2030.
- In terms of segment, vitamins & minerals was the largest revenue generating product in 2022.
- Herbal Extracts is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2023 to 2030.
Asia Pacific data book summary
| Market revenue in 2022 | USD 4,611.6 million |
| Market revenue in 2030 | USD 11,585.1 million |
| Growth rate | 12.2% (CAGR from 2022 to 2030) |
| Largest segment | Vitamins & minerals |
| Fastest growing segment | Herbal Extracts |
| Historical data covered | 2017 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vitamins & Minerals, Herbal Extracts, Natural Molecules |
| Key market players worldwide | Amway Malaysia Holdings, Klaire Labs, Nordic Naturals, Himalaya Wellness, Nu Skin Enterprises Inc Class A, Pfizer Inc, NOW Foods, Natures Sunshine Products Inc, Wakunaga Pharmaceutical, Neurobiologix Supplements, Parkway Products, Vitamin Shoppe |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 30.2% of the global cold and flu supplements market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Europe is the fastest growing regional market and is projected to reach USD 9,849.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cold And Flu Supplements Market Scope
Cold And Flu Supplements Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific cold and flu supplements market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cold and flu supplements market will help companies and investors design strategic landscapes.
Vitamins & minerals was the largest segment with a revenue share of 39.62% in 2022. Horizon Databook has segmented the Asia Pacific cold and flu supplements market based on vitamins & minerals, herbal extracts, natural molecules covering the revenue growth of each sub-segment from 2017 to 2030.
The demand for cold and flu supplements is growing in the Asia Pacific region due to factors like high population density, urbanization, and increased virus exposure. Traditional medicine practices also contribute to this demand, with herbal remedies playing a significant role.
The COVID-19 pandemic further highlighted the potential of herbal medicines, as a study published in October 2021 suggested their effectiveness in treating and preventing the virus by targeting various aspects such as viral-host interaction, immune system, and molecular targets.
In Traditional Chinese Medicine (TCM), herbal medicines were often prescribed alone or in combination with modern synthetic drugs for COVID-19 patients.
Reasons to subscribe to Asia Pacific cold and flu supplements market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific cold and flu supplements market databook
-
Our clientele includes a mix of cold and flu supplements market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cold and flu supplements market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cold and flu supplements market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific cold and flu supplements market size, by country, 2017-2030 (US$M)
Asia Pacific Cold And Flu Supplements Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
